Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial
Open accessThe DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
Abstract
Background Continuous glucose monitoring, either real-time (personal) or retrospective (professional mode), can identify day-to-day glucose profiles to guide management decisions for people with type 2 diabetes. We aimed to examine the effects of professional-mode flash glucose monitoring, done at 3-month intervals, in adults with type 2 diabetes in general practice. Methods We did a pragmatic, two-arm, open label, 12-month, individually randomised controlled trial (GP-OSMOTIC) in 25 general practices in Victoria, Australia. Eligible participants were adults aged 18-80 years, with type 2 diabetes diagnosed for at least 1 year and HbA 1c at least 5·5 mmol/mol (0·5%) above their target in the past month despite being prescribed at least two non-insulin glucose-lowering drugs, insulin, or both (with therapy stable for at least 4 months). We randomly assigned participants (1:1) to either use of a professional-mode flash glucose monitoring system or usual clinical care (control). All participants wore the flash glucose monitoring sensor at baseline, and electronic randomisation (using permuted block sizes of four and six, and stratified by clinic) was done after the sensor was attached. Masking of participants and treating clinicians to group allocation was not possible, but the study statistician was masked to allocation when analysing the data. At baseline, and 3, 6, 9, and 12 months, participants in the flash glucose monitoring group wore the professional-mode flash glucose mon…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetes Care · doi:10.2337/dci18-0033 · Cited by 3,518
International consensus on use of continuous glucose monitoring
Danne, T., Nimri, R., Battelino, T., Bergenstal, R. M., Close, K. L., DeVries, J. H., Garg, S., Heinemann, L., Hirsch, I., Amiel, S. A., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1600 · Cited by 2,069
Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials
Beck, R. W., Bergenstal, R. M., Riddlesworth, T. D., Kollman, C., Li, Z., Brown, A. S., & Close, K. L. (2019) · Diabetes Care · doi:10.2337/dc18-1444 · Cited by 793
Haak, T., Hanaire, H., Ajjan, R., Hermanns, N., Riveline, J.-P., & Rayman, G. (2017) · Diabetes Therapy · doi:10.1007/s13300-016-0223-6 · Cited by 623
Polonsky, W. H., Fisher, L., Schikman, C. H., Hinnen, D. A., Parkin, C. G., Jelsovsky, Z., Petersen, B., Schweitzer, M., & Wagner, R. S. (2011) · Diabetes Care · doi:10.2337/dc10-1732 · Cited by 429
Khunti, K., Ceriello, A., Cos, X., & De Block, C. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.12.004 · Cited by 200
Self-citationAllen, N. A., Fain, J. A., Braun, B., & Chipkin, S. R. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.01.006 · Cited by 182
Wright, L. A.-C., & Hirsch, I. B. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0029 · Cited by 178
Farmer, A. J., Perera, R., Ward, A., Heneghan, C., Oke, J., Barnett, A. H., Davidson, M. B., Guerci, B., Coates, V., Schwedes, U., et al. (2012) · BMJ · doi:10.1136/bmj.e486 · Cited by 156
Taylor, P. J., Thompson, C. H., & Brinkworth, G. D. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12807 · Cited by 115
Research works printed but not linked: 1
- Young, 2015, Examining the role of continuous glucose monitoring (CGM) in noninsulin treated type 2 diabetes, Diabetes, 64, A236
Cited by
Grunberger, G., Sherr, J., Allende, M., Blevins, T., Bode, B., Handelsman, Y., Hellman, R., Lajara, R., Roberts, V. L., Rodbard, D., et al. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.04.008 · Cited by 288
Seidu, S., Kunutsor, S. K., Ajjan, R. A., & Choudhary, P. (2024) · Diabetes Care · doi:10.2337/dc23-1520 · Cited by 124
Technology in the management of type 2 diabetes: Present status and future prospects
DALY, A. B., & Hovorka, R. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14418 · Cited by 108
A review of flash glucose monitoring in type 2 diabetes
Krakauer, M., Botero, J. F., Lavalle-González, F. J., Proietti, A., & Barbieri, D. E. (2021) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-021-00654-3 · Cited by 71
Uhl, S., Choure, A., Rouse, B., Loblack, A., & Reaven, P. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad652 · Cited by 76
Metadata
- Authors
- Furler, J., O'Neal, D., Speight, J., Blackberry, I., Manski-Nankervis, J.-A., Thuraisingam, S., de La Rue, K., Ginnivan, L., Doyle, R., Holmes-Truscott, E., Khunti, K., Dalziel, K., Chiang, J., Audehm, R., Kennedy, M., Clark, M., Jenkins, A., Lake, A. J., Januszewski, A. S., Catchpool, M., Liew, D., Clarke, P., & Best, J.
- Affiliations
- The University of Melbourne (AU)
- Deakin University (AU)
- La Trobe University (AU)
- University of Leicester (GB)
- The University of Sydney (AU)
- Monash University (AU)
- Nanyang Technological University (SG)
- Corresponding author
- Furler, John
- ORCID
- Venue
- The Lancet Diabetes & Endocrinology
- Publisher
- Elsevier BV
- Published
- 2020-01
- Volume
- 8
- Issue
- 1
- Pages
- 17-26
- ISSN
- 2213-8587 (ISSN-L)
- OpenAlex
- W2995952001
- Cited by
- 55
- References
- 28
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 5 · 2023: 10 · 2022: 7 · 2021: 12 · 2020: 5
- FWCI
- 5.07
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- The Lancet Diabetes & Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- National Health and Medical Research Council (APP1104241)
- Deakin University
- Novo Nordisk
- Roche
- AstraZeneca Australia
- Sanofi Australia
- National Institute for Health and Care Research
- Center for Outcomes Research and Evaluation, Yale School of Medicine
- National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care Yorkshire and Humber
- Boehringer Ingelheim
- NIHR Leicester Biomedical Research Centre
- Abbott Diabetes Care
- Diabetes Victoria
- Manchester Biomedical Research Centre
- Sydney Medical School Foundation
- Medtronic
- Collaboration for Leadership in Applied Health Research and Care - Greater Manchester
- Sanofi
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- flash glucose monitoring, type 2 diabetes, HbA1c, glycemic control, ambulatory glucose profile, time in target glucose range, diabetes distress, general practitioner care, primary care, diabetes management, HbA1c targets, Problem Areas in Diabetes scale, HbA1c variability, HbA1c trends
- MeSH terms
- Aged, Diabetes Mellitus, Type 2, Female, Humans, Male, Middle Aged, Monitoring, Physiologic, Blood Glucose Self-Monitoring, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial. https://app.cochat.ai/papers/10.1016/s2213-8587(19)30385-7
- The paper
- Furler, J., O'Neal, D., Speight, J., Blackberry, I., Manski-Nankervis, J.-A., Thuraisingam, S., de La Rue, K., Ginnivan, L., Doyle, R., Holmes-Truscott, E., Khunti, K., Dalziel, K., Chiang, J., Audehm, R., Kennedy, M., Clark, M., Jenkins, A., Lake, A. J., Januszewski, A. S., . . . Best, J. (2020). Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial. The Lancet Diabetes & Endocrinology. https://doi.org/10.1016/s2213-8587(19)30385-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.